Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555880 · ClinicalTrials.gov registry record · Phase 4
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00555880 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 24 participants.
The verdict
NCT00555880, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate the clinical effect of midodrine hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by measuring the time to onset of near syncopal symptoms and assessing several cardiovascular measurements, such as heart rate, blood pressure, and ECG, using the tilt table test.
Interventions
- DRUG Placebo
- DRUG Midodrine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-09-08 |
| Est. Completion | 2005-03-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555880
The ClinicalTrials.gov registry entry for NCT00555880 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00555880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00555880 about?
NCT00555880 is a clinical study titled "Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension". The purpose of this clinical study is to evaluate the clinical effect of midodrine hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by measuring the time to onset of near syncopal symptoms and assessing several cardiovascular measurements, such as heart rate, ...
What is the current status of trial NCT00555880?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2004-09-08. Estimated completion is 2005-03-21.
What interventions are being tested in trial NCT00555880?
The interventions under investigation include: Placebo (DRUG), Midodrine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00555880?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.